Exposure-efficacy relationship of vedolizumab subcutaneous and intravenous formulations in Crohn's disease and ulcerative colitis

CONCLUSION: Exposure-efficacy relationships for IV and SC vedolizumab administration were comparable, confirming that both are equally effective during maintenance treatment.PMID:38441048 | DOI:10.1080/17512433.2024.2318465

Source: Expert Review of Clinical Pharmacology - March 5, 2024 Category: Drugs & Pharmacology Authors: Geert D'Haens Maria Rosario Daniel Polhamus Nathanael L Dirks Chunlin Chen Krisztina Kisfalvi Christian Agboton S éverine Vermeire Brian G Feagan William J Sandborn Source Type: research